Encapsulation of glucose oxidase in Fe(III)/tannic acid nanocomposites for effective tumor ablation via Fenton reaction

Keke Du,Qianqian Liu,Mei Liu,Rongmu Lv,Nongyue He,Zhifei Wang
DOI: https://doi.org/10.1088/1361-6528/ab44f9
IF: 3.5
2019-10-08
Nanotechnology
Abstract:Increasing the content of reactive oxygen species (ROS) with the assistance of nanoformulations in cancer cells via Fenton reaction is considered to be an effective method to treat cancer. However, the efficiency of Fenton reaction is affected by the level of H<sub>2</sub>O<sub>2</sub>, the selection of iron ions in different nanoformulations, etc. Herein, we use the Fe<sup>III</sup>-tannic acid (Fe<sup>III</sup>TA) nanocomposites as the carrier to deliver glucose oxidase (GOD) that can solve the problem of insufficient endogenous H<sub>2</sub>O<sub>2</sub> by catalytically converting the glucose. In comparison with traditional Fe<sup>2+</sup>/Fe<sup>3+</sup>, Fe<sup>III</sup>TA nanocomposites perform higher catalytic activity in converting H<sub>2</sub>O<sub>2</sub> to high toxic hydroxyl radicals (•OH) due to the TA-mediated reduction of Fe<sup>3+</sup>. So, the integration of GOD and TA in the construction of nanocomposites significantly enhances the efficiency of Fenton reaction. In vitro experiments show that •OH produced by GOD-Fe<sup><sup>III</sup></sup>TA nanocomposites can not only achieve a good anticancer effect at a low concentration but also promote degradability of the nanocomposites. When it is only 1.08 μg•mL<sup>-1</sup>, the cell apoptosis rate has reached 76.91%. And in vivo experiments further demonstrate that GOD-Fe<sup>III</sup>TA nanocomposites can significantly inhibit the tumor growth. So this work lays a good foundation for Fenton reaction-based cancer treatment.
materials science, multidisciplinary,physics, applied,nanoscience & nanotechnology
What problem does this paper attempt to address?